Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1873 1
1935 1
1947 5
1948 1
1950 18
1951 16
1952 11
1953 11
1954 6
1955 3
1956 8
1957 5
1958 6
1959 2
1960 6
1961 6
1962 3
1963 12
1964 13
1965 6
1966 9
1967 20
1968 79
1969 82
1970 102
1971 144
1972 172
1973 211
1974 332
1975 321
1976 336
1977 357
1978 584
1979 741
1980 468
1981 405
1982 429
1983 571
1984 631
1985 712
1986 610
1987 566
1988 687
1989 742
1990 792
1991 1157
1992 1481
1993 1893
1994 1951
1995 1815
1996 1721
1997 1888
1998 1806
1999 1808
2000 1652
2001 1867
2002 1856
2003 2017
2004 2194
2005 2035
2006 2180
2007 2219
2008 2240
2009 2498
2010 2705
2011 2759
2012 3066
2013 3017
2014 3183
2015 3070
2016 2937
2017 2915
2018 3026
2019 2958
2020 2774
2021 2399
2022 2128
2023 1980
2024 790

Text availability

Article attribute

Article type

Publication date

Search Results

81,087 results

Results by year

Filters applied: . Clear all
Page 1
The ethics and economics of pharmaceutical pricing.
Parker-Lue S, Santoro M, Koski G. Parker-Lue S, et al. Annu Rev Pharmacol Toxicol. 2015;55:191-206. doi: 10.1146/annurev-pharmtox-010814-124649. Epub 2014 Aug 13. Annu Rev Pharmacol Toxicol. 2015. PMID: 25149920 Review.
The cost of drugs is a major and rapidly rising component of health-care expenditures. We survey recent literature on the ethics and economics of skyrocketing pharmaceutical prices and find that advances in economic research have increased the sharpness and focus of …
The cost of drugs is a major and rapidly rising component of health-care expenditures. We survey recent literature on the ethics and …
Impact of European pharmaceutical price regulation on generic price competition: a review.
Puig-Junoy J. Puig-Junoy J. Pharmacoeconomics. 2010;28(8):649-63. doi: 10.2165/11535360-000000000-00000. Pharmacoeconomics. 2010. PMID: 20515079 Review.
Although economic theory indicates that it should not be necessary to intervene in the generic drug market through price regulation, most EU countries intervene in this market, both by regulating the maximum sale price of generics (price cap) an …
Although economic theory indicates that it should not be necessary to intervene in the generic drug market through price regulatio …
Does drug price-regulation affect healthcare expenditures?
Ben-Aharon O, Shavit O, Magnezi R. Ben-Aharon O, et al. Eur J Health Econ. 2017 Sep;18(7):859-867. doi: 10.1007/s10198-016-0832-z. Epub 2016 Sep 30. Eur J Health Econ. 2017. PMID: 27696009 Free PMC article.
A variety of cost containment tools are used to control this trend, including maximum price regulation and reimbursement methods for health technologies. ...No association was found between price regulation or reimbursement mechanisms and …
A variety of cost containment tools are used to control this trend, including maximum price regulation and reimb …
Monitoring the price and affordability of foods and diets globally.
Lee A, Mhurchu CN, Sacks G, Swinburn B, Snowdon W, Vandevijvere S, Hawkes C, L'abbé M, Rayner M, Sanders D, Barquera S, Friel S, Kelly B, Kumanyika S, Lobstein T, Ma J, Macmullan J, Mohan S, Monteiro C, Neal B, Walker C; INFORMAS. Lee A, et al. Obes Rev. 2013 Oct;14 Suppl 1:82-95. doi: 10.1111/obr.12078. Obes Rev. 2013. PMID: 24074213 Review.
Food prices and food affordability are important determinants of food choices, obesity and non-communicable diseases. ...This paper briefly reviews past and current approaches to monitoring food prices, and identifies key issues affecting the development of practica …
Food prices and food affordability are important determinants of food choices, obesity and non-communicable diseases. ...This paper b …
When Is The Price Of A Drug Unjust? The Average Lifetime Earnings Standard.
Emanuel EJ. Emanuel EJ. Health Aff (Millwood). 2019 Apr;38(4):604-612. doi: 10.1377/hlthaff.2018.05052. Health Aff (Millwood). 2019. PMID: 30933574 Review.
Yet drug costs as a proportion of the country's medical expenditures have increased substantially in recent years. ...This suggests that current prices for many drugs are excessive and unjust....
Yet drug costs as a proportion of the country's medical expenditures have increased substantially in recent years. ...This suggests t …
Cross-national drug price comparisons with economic weights in external reference pricing in Germany.
Mahlich J, Sindern J, Suppliet M. Mahlich J, et al. Expert Rev Pharmacoecon Outcomes Res. 2019 Feb;19(1):37-43. doi: 10.1080/14737167.2019.1527221. Epub 2018 Oct 14. Expert Rev Pharmacoecon Outcomes Res. 2019. PMID: 30273062 Review.
BACKGROUND: Since 2012, the pharmaceutical reimbursement legislation in Germany has been applying external reference pricing that uses country-specific economic weights for foreign prices. ...In a second step, we populate the weighting schemes with economic d …
BACKGROUND: Since 2012, the pharmaceutical reimbursement legislation in Germany has been applying external reference pricing t …
Specialty Drug Price Trends in the Federal 340B Drug Discount Program.
Lee CH, Chang J, McCombs J. Lee CH, et al. J Manag Care Spec Pharm. 2019 Feb;25(2):178-187. doi: 10.18553/jmcp.2019.25.2.178. J Manag Care Spec Pharm. 2019. PMID: 30698090 Free PMC article.
RESULTS: The 340B price growth rate patterns were similar to the profile of the WAC prices over time across all drug classes. The overall drug price growth rate per year over 10 years for WAC prices was 15% and 10% for 340B prices. ...
RESULTS: The 340B price growth rate patterns were similar to the profile of the WAC prices over time across all drug classes. …
Coping With Concentration.
Greaney TL. Greaney TL. Health Aff (Millwood). 2017 Sep 1;36(9):1564-1571. doi: 10.1377/hlthaff.2017.0558. Health Aff (Millwood). 2017. PMID: 28874482
Provider market power is a powerful driver of high health care costs in the United States. Despite decades of antitrust litigation and regulatory interventions, the problem has worsened and threatens to undermine the benefits of market-based policies. ...Although not witho …
Provider market power is a powerful driver of high health care costs in the United States. Despite decades of antitrust litigation an …
Price and utilisation differences for statins between four countries.
Thai LP, Vitry AI, Moss JR. Thai LP, et al. Expert Rev Pharmacoecon Outcomes Res. 2018 Feb;18(1):71-81. doi: 10.1080/14737167.2017.1366856. Epub 2017 Aug 21. Expert Rev Pharmacoecon Outcomes Res. 2018. PMID: 28800399
INTRODUCTION: Australia, England, France and New Zealand use different policies to regulate their medicines market, which can impact on utilisation and price. ...There were large differences between the Laspeyres index and Paasche index when comparing the price …
INTRODUCTION: Australia, England, France and New Zealand use different policies to regulate their medicines market, which can impact …
Getting the Price Right: How Nutrition and Obesity Prevention Strategies Address Food and Beverage Pricing Within High-Income Countries.
Zorbas C, Grigsby-Duffy L, Backholer K. Zorbas C, et al. Curr Nutr Rep. 2020 Mar;9(1):42-53. doi: 10.1007/s13668-020-00300-w. Curr Nutr Rep. 2020. PMID: 31953676 Review.
RECENT FINDINGS: Policy strategies were inconsistent and fragmented in their inclusion of food prices as determinants of diet-related health. The equity benefits of pricing policies were often indicated. Fiscal measures and food subsidies in schools were the most co …
RECENT FINDINGS: Policy strategies were inconsistent and fragmented in their inclusion of food prices as determinants of diet-related …
81,087 results
You have reached the last available page of results. Please see the User Guide for more information.